Insulin stimulates protein synthesis in muscle, but the exact means by which the hormone does so is an unsolved problem.1 In venturing an analysis of that problem, one is fortunate in being able to rule out some possibilities. The stimulation of protein synthesis is not secondary to an increase in the transport into the cell of glucose2' 3or amino acids.4-7 Insulin, to be sure, does increase the entry of both into muscle, but the hormone can stimulate protein synthesis without increased substrate transport-an observation that suggested that, at least with respect to protein synthesis, the effect of insulin is on some intracellular process. The intracellular process, however, is not RNA synthesis, for, once again, even though insulin does increase RNA synthesis in muscle, the increase is not necessary for the stimulation of protein synthesis.8' Indeed, RNA synthesis can be all but completely inhibited with actinomycin without interfering with the effect of insulin to increase protein synthesis; for that matter, actinomycin does not alter any of a number of other characteristic actions of insulin on muscle.8' 9 The experiments with actinomycin led us to reappraise the problem and to the realization that there were two observations of some significance that had been lost sight of: that insulin acts rapidly to increase protein synthesis-a definite response occurs in muscle within 5 min;10 and that messenger RNA in muscle turns over relatively slowly.9' 11 If the control of protein synthesis by insulin is rapid, and if messenger RNA in muscle is relatively stable, then it is unlikely that it is the modulation of the transcription of RNA that is the basis for the hormone's effect.
The analysis of the problem was materially aided by the demonstration that ribosomes from heart muscle of rats would catalyze the transfer of significant amounts of radioactivity from sRNA-C14-phenylalanine into protein. 12 Using that system, we found:"3 (1) that insulin added in vitro to heart muscle ribosomes did not alter their ability to carry out protein synthesis; (2) that ribosomes from animals made diabetic with alloxan would incorporate less amino acid into protein; and (3) that administration of insulin to normal and, especially, to diabetic animals 1 hr before they were killed and their ribosomes isolated led to increased protein synthesis. Since the assay was carried out so that protein synthesis was directly proportional to the number of ribosomes, and since the effects persisted in the presence of saturating amounts of polyuridylic acid, we concluded that the changes could not be due solely to alterations in the amount of template RNA associated with the ribosome.13 That conclusion was reinforced by the results of experiments with ribosomes stripped of their endogenous messenger RNA.14 Polyuridylic acid, in concentrations of 1-200 jug/ml, was added to stripped (i.e., preincubated) ribosomes from ment increased the number of aminoacyl transfers. We concluded that the locus of insulin action was the ribosome, and that perhaps the hormone altered the ribosome in a way that modified the translation of preformed messenger RNA.
Insulin's lack of effect when added in vitro to ribosomes was both disappointing and puzzling although, as with all negative experiments, failure to observe an effect cannot be conclusive. But the results did suggest that either some component essential for insulin action was lacking in the assay system, or that insulin is not the actual mediator of increased protein synthesis. The experiments reported here bear on the problem.
We have been aware how important it is to determine the biochemical changes that occur in the hour between the administration of insulin to the animal and the isolation of the ribosomes. The question we have asked is whether protein and RNA synthesis are required for the insulin-mediated change in ribosomal protein synthesis. To assist in answering the question we have used several antibioticspuromycin and cycloheximide to block protein synthesis, and actinomycin to inhibit RNA synthesis. The inspiration for the study came in part from the elegant experiments of Garren et al. '5 In the experiments reported here, we used ribosomes from skeletal rather than cardiac muscle; greater amounts of the former can be obtained from each animal, thus effecting a great economy. The response of skeletal and cardiac muscle ribosomes to diabetes and insulin administration is quite similar.
Materials and Methods.-Animals: Male Sprague-Dawley rats weighing approximately 100-140 gm were maintained under standard conditions3 and allowed free access to food and water. Diabetes was induced by rapid intravenous injection of 60 mg/kg of alloxan monohydrate to rats starved overnight, and the animals were used 4 days later.
Materials: The U-C'4-phenylalanine (297 mc/mmole), the Hs-uridine (7.77 c/mmole), and the H'-5-orotic acid (233 mc/mmole) were purchased from New England Nuclear Corp.; alloxan monohydrate from Eastman Kodak Company; glucose oxidase from Worthington Biochemicals Corp. The insulin (beef zinc insulin crystals, lot PJ4609) assaying 24 units/mg and containing less than 0.003% glucagon, was a gift of Dr. 0. Behrens of Eli Lilly and Co.; it was dissolved in N/300 hydrochloric acid to form a stock solution of 20 units/ml. The actinomycin C, (D) was a gift of Dr. C. A. Stone of Merck, Sharp and Dohme Research Laboratories; it was dissolved in 2% ethanol in saline to give a concentration of 0.5 mg/ml. The puromycin dihydrochloride, the aminonucleoside, and the cycloheximide were purchased from Nutritional Biochemicals Corp.
Preparation of skeletal muscle ribosomes: Ribosomes were prepared from the thigh and gastrocnemius muscles from 3-10 animals by the method described by Florini and Breuer. "6 Soluble RNA from Escherichia coli was charged with C'4-phenylalanine and 19 additional C"2-amino acids."7 The "transfer enzyme" (105,000 g supernatant protein) was prepared from the soluble fraction of a homogenate of rat liver. '3 In the assay, the number of aminoacyl transfers from sRNA-C'4-phenylalanine to protein was proportional to the number of ribosomes, and in all cases equal numbers of ribosomes from control and experimental groups were compared. The exact conditions of the assay are in the legends to the tables.
Chemical analysis: Ribosomal RNA was determined by the method of Fleck and Munro,18 '9 and the number of ribosomes adjusted prior to assay.
To determine incorporation of radioactivity into protein, the reaction was terminated by the addition of 5 ml of 10% trichloroacetic acid, and the sample was heated at 90-950C for 15 min to hydrolyze RNA. The sample was cooled and passed through a Millipore filter (type HA with a pore size of 0.45 A) and washed with 50 ml of 5% trichloroacetic acid containing 1 mg/ml of C"2-phenylalanine. The Millipore filter containing the sample was placed in a counting vial. The protein was dissolved in 0.7 ml of 88% formic acid and 15 ml of dioxane-containing scintillation fluid was added; the radioactivity was measured in a Packard Tri-Carb liquid scintillation counter. In the experiments (Tables 4 and 5 ) in which synthesis in vivo was assayed, the protein was isolated and the radioactivity determined by a method described before. 12 The specific radioactivity of RNA was determined in the following manner: Hemidiaphragm after incubation in vitro' (or in the in vivo experiments, a sample of liver or thigh muscle) was homogenized in 20 ml of cold 10% trichloroacetic acid for 1 min at a rheostat setting of 80 in a VirTis "45" homogenizer; the precipitate was collected by centrifugation and washed 4 times with cold 0.02 M perchloric acid. The procedure was carried out at 40C. The RNA was isolated from the perchloric acid precipitate by the method of Fleck and Munro;'58 19 the concentration of RNA was estimated from the optical density at 260 msA in a Beckman model DU spectrophotometer; and the radioactivity was determined by adding a 1-ml sample to a dioxane containing scintillation fluid and counting in a Packard Tri-Carb liquid scintillation counter.
The blood glucose concentration was determined by the glucose oxidase (EC 1.1.3.4) method.20
Results.-Effect of diabetes and insulin on protein synthesis by skeletal muscle ribosomes: Skeletal muscle ribosomes from alloxan-diabetic animals were about 60 per cent less effective than ribosomes from control animals in the transfer of radioactivity from sRNA-C14-phenylalanine into protein (Table 1; cf. Tables 2, 6 , 8, and 9). Ribosomes from diabetic animals treated within insulin 1 hr before they were killed carried out 125 per cent more protein synthesis than ribosomes from untreated diabetic animals (Table 1) ; generally, insulin restored synthesis to normal or near-normal levels.
Effect of diabetes and insulin on protein synthesis by skeletal muscle ribosomes in the presence of puromycin and cycloheximide: Control and diabetic animals were given 300 mg/kg of puromycin; 75 min later, half the diabetic animals received insulin; all the animals were killed 135 min after the antibiotic (60 min after insulin), and the ribosomes were isolated from skeletal muscle and used in an assay of protein synthesis ( Table 2 ). The puromycin inhibited ribosomal protein synthesis slightly (17%) in one case (Table 2 ), but definitely (41%) when re-examined in a separate experiment (Table 3) . It had no influence, however, on the defect in ribosomal protein synthesis that occurs in The animals each received (intraperitoneally) either 300 mg/kg of puromycin or an equal volume of saline; 75 min later they were given (intraperitoneally) 5 units of insulin or an equal volume of saline. The animals were killed 135 min after the first injection (puromycin or saline)-1 hr after the insulin (or saline)-and the ribosomes were isolated and assayed as described in that protein synthesis was necessary for the insulin effect. We felt the conclusion would be reinforced if another inhibitor of protein synthesis was equally effective in blocking the insulin stimulation, especially if the second inhibitor had a different mechanism of action. Cycloheximide blocks protein synthesis; the antibiotic is structurally different from puromycin and is thought to act in a different manner. 21 Cycloheximide (5 mg) inhibited (by 96%) protein synthesis by muscle in vivo (Table 5 ). The antibiotic also caused a 29 per cent decrease in ribosome-catalyzed incorporation of radioactivity from sRNA-C14-phenylalanine into protein (Table 6 ).
Nonetheless, ribosomes from all diabetic animals, both those that received cycloheximide and those that did not, manifested a similar degree of deficiency in transfer of aminoacyl groups from sRNA to protein. But most importantly, and most critically, ribosomes from diabetic animals treated with cycloheximide failed to respond to insulin, whereas ribosomes from diabetic animals not treated with the antibiotic did ( Table 6 ).
Effect of diabetes and insulin on protein synthesis by skeletal muscle ribosomes in the presence of actinomycin: In a parallel experiment, actinomycin (1 mg) inhibited by 95 per cent in vivo synthesis of RNA by the liver ( ( Table 7 ). The tissue probably recovered somewhat from the inhibitory effect of actinomycin during the in vitro assay, and actual inhibition in vivo was as great in muscle as in liver. Actinomycin treatment did not affect the capacity of ribosomes to incorporate amino acid into protein (Table 8 , expts. I and II); neither did the antibiotic prevent the development of the defect in ribosomal protein synthesis that occurs in the absence of insulin. M\'Joreover, the suppression of RNA synthesis with actinomycin in no way interfered with the ability of insulin to increase ribosomal capacity for protein synthesis (Table 8) .
Time required for the insulin effect on ribosomes: Some clue as to the biochemical basis for the action of insulin might come from a knowledge of how rapidly the hormone can increase ribosomal synthesis of protein. For example, an effect of the hormone on the translation of preformed messenger RNA might occur more quickly than an effect on transcription, especially since the turnover of messenger RNA in muscle is a relatively slow process. To determine the time required for insulin to act, increasing amounts of the hormone were administered to diabetic animals at decreasing intervals of time before they were killed and the ribosomes isolated and assayed. At the shortest interval tested, 5 min, insulin had produced a 44 per cent increase in protein synthesis (Table 9 ). 470 ± 69 (6 vs. 5)
The animals each received (intraperitoneally) 5 mg of cycloheximide or an equal volume of saline and, 15 min later, 5 units of insulin or an equal volume of saline. The animals were killed 75 min after the first injection (cycloheximide or saline)-1 hr after the insulin (or saline)-and the ribosomes were isolated and assayed as described in Table 1 , except that 125 pg of sRNA from Escherichia coli charged with C14Lphenylalanine (6.81 X 10 cpm) and 60 pg of ribosomal RNA were added. Each 100 cpm of radioactivity in protein is the result of the incorporation of 2.69 X 10-1 pplmole of phenylalanine. The blood glucose values are the mean 4 S.E.M. of four observations. The animals each received 1 mg of actinomycin, or an equal volume of 2% ethanol in saline. The actinomycin or saline was administered intraperitoneally in all except one experiment in which it was given intravenously. For the in vitro experiments the animals were killed at the time interval after administration of actinomycin that is specified; the hemidiaphragms wvere removed and incubated for 1 hr at 370 in 2 ml of Krebs-Henseleit bicarbonate buffer containing 10 Pc/ml of H1-uridine. For the in vivo experiment either 200 sac of H'-orotic acid (liver) or 600 tic of H'-uridine (thigh muscle) were administered 1 hr before the animal was killed; the time interval after actinomycin is specified. The RNA in the tissue was isolated and its specific radioactivity determined. The values are the mean of two or three observations.
Discussion.-The experiments recounted here seem to establish quite decisively that protein synthesis, but not DNA-dependent RNA synthesis, is necessary for the stimulation by insulin of protein synthesis by muscle ribosomes. Taken together, the observations can be provisionally interpreted as follows: Insulin acts first to bring about the synthesis of a "specific protein," and it does so by modulating translation of its stable template RNA. The former conclusion rests on the observation that puromycin and cycloheximide block the hormone's effect on the ribosome; the conclusion that insulin acts by influencing translation rather than transcription of RNA rests on the observation that actinomycin does not interfere with the hormone's action. The specific, but still hypothetical, protein then serves in the modulation of the translation of other species of stable messenger RNA, perhaps in a cascadelike fashion, in that way accounting for the larger effect of insulin on protein synthesis in muscle. The interpretation is not unlike that suggested by Garren et al."5 to account for ACTH regulation of corticosterone production in the adrenal cortex. Moreover, if the interpretation is correct, it explains why insulin fails to act when added in vitro to a cell-free ribosomal system, since it may well be the "specific protein" rather than insulin that is responsible for modifying ribosomal function. That insulin can appreciably increase protein synthesis in as short a time as 5 min appears to us to accord with the idea that it acts on translation of messenger RNA rather than on transcription-that is, if one presumes that the former can occur more rapidly than the latter in tissues like muscle, where messenger RNA is relatively stable. The speed with which insulin acts is quite remarkable; indeed, we know of no other biological agent or circumstance that can more rapidly stimulate synthesis of protein by ribosomes from a mammalian tissue.
The experiments do not identify the site of synthesis of the "specific protein." It is possible, but not likely, that the protein is synthesized in some tissue or organ other than muscle and is itself then a hormone-a hormone on whose synthesis and release insulin exerts a tropic effect. A more plausible view, however, is that the "specific protein" is synthesized in muscle; that interpretation accords with the ob- The animals received (intraperitoneally) the amount of insulin specified, or an equal volume of saline, and were killed at the time after insulin that is indicated (or 30 min after saline), and the ribosomes were isolated and assayed as described in Table 1 , except that 125 pg of aRNA-charged C1-phenylalanine (9.08 X 103 cpm) and 61 pg of ribosomal RNA were added. Each 100 cpm of radioactivity in protein is the result of the incorporation of 3.20 X 10-1 ppmole phenylalanine. The blood glucose values are the mean i S.E.M. of four observations. servation that insulin will increase protein synthesis whenadded in vitro to diaphragm muscle. 22 The response of skeletal muscle ribosomes from diabetic animals to protein fractions from muscle and other tissues could serve to help establish the source and the identity of the "specific protein." Both puromycin (Tables 2 and 3 ) and cycloheximide (Table 5 ) administered in vivo decreased ribosomal synthesis of protein as assayed in vitro. While it is possible that the inhibition was due to small amounts of the antibiotics that were not removed during preparation of the ribosomes, it is equally possible that the antibiotics inhibited the synthesis in vivo of the "specific protein" and were responsible in that way for the decreased ribosomal synthesis of protein. The latter interpretation is supported by the observation that puromycin had no effect on ribosomes from diabetic animals-which presumably were not making the specific protein-and that cycloheximide had a lesser effect on ribosomes from diabetic than from normal animals (cf. especially the experiment with puromycin, Table 2 ).
Furthermore, there is evidence that cycloheximide decreases protein synthesis by inhibiting the action of transfer factor II,21 the cytoplasmic enzyme (peptide synthetase) that catalyzes formation of the peptide bond.23 Cycloheximide is, therefore, less likely to contaminate the ribosomes than is puromycin, which binds to the ribonucleoprotein particles. Moreover, the "transfer factor preparation" which we used in the assay was prepared from the livers of animals which had not been treated with cycloheximide. Still, cycloheximide administered in vivo was at least as effective as puromycin in decreasing ribosomal protein synthesis.
The defect in protein synthesis due to insulin deficiency was not altered by cycloheximide or puromycin, and hence, would not appear to depend on synthesis of a protein inhibitor, at least not one with a relatively short half life.
It has not escaped our notice that the "specific protein"-or more properly, its lack-might help to account for some of the biochemical derangements of diabetics, not for the hypoglycemic action of insulin, however, for that occurs even after protein synthesis is inhibited by puromycin or cycloheximide (Tables 2 and 5 ). But the "specific protein" might be an intermediate in certain effects insulin has on foodstuff metabolism.
